Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Synonyms||Allogeneic Anti-BCMA-CAR T-cells PBCAR269A|
PBCAR269A are allogeneic T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeted against B-cell maturation antigen (BCMA), potentially resulting in increased death of tumor cells expressing BCMA (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Cyclophosphamide + Fludarabine + Nirogacestat + PBCAR269A||Cyclophosphamide Fludarabine Nirogacestat PBCAR269A||0||1|
|Cyclophosphamide + Fludarabine + PBCAR269A||Cyclophosphamide Fludarabine PBCAR269A||0||1|